Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2002
11/21/2002WO2002092073A1 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
11/21/2002WO2002092067A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/21/2002WO2002092064A2 Therapeutic method for inducing tolerance
11/21/2002WO2002092054A2 Immune modulation device for use in animals
11/21/2002WO2002092032A1 Use of 3-position cyclosporin derivatives for hair growth
11/21/2002WO2002092011A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002WO2002091996A2 Methods for treating cancer
11/21/2002WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases
11/21/2002WO2002074981A3 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
11/21/2002WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002WO2002043785A3 Intraocular implants for preventing transplant rejection in the eye
11/21/2002WO2002022169A3 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS
11/21/2002WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002WO2002000730A3 Pd-l2 molecules: novel pd-1 ligands and uses therefor
11/21/2002WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/21/2002WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002WO2001017559A9 Semaphorin modulation of immune cell migration
11/21/2002US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002US20020173655 Thioether substituted imidazoquinoline or tetrahydroimdazoquinoline compounds induce the biosynthesis of cytokines such as interferon and useful for treating viral disease in an animal
11/21/2002US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002US20020173648 Use in the treatment of PDE4 and TNF mediated diseases
11/21/2002US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002US20020173638 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer
11/21/2002US20020173625 Hybrid polypeptide for use in the treatment and prevention of allergic disorders
11/21/2002US20020173540 Using plant extract
11/21/2002US20020173528 Agonists specific for the peripheral cannabinoid receptor
11/21/2002US20020173527 Tumor necrosis factor antagonist; antiinflammatory agents
11/21/2002US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002US20020173520 Quinoline derivatives
11/21/2002US20020173519 Quinoline derivatives
11/21/2002US20020173515 Antiproliferative agents
11/21/2002US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002US20020173506 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists
11/21/2002US20020173499 Estrogen replacement therapy
11/21/2002US20020173496 Formulation containing novel anti-inflammatory androstane derivative
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020173477 Antiallergens
11/21/2002US20020173464 Modulation of pericyte proliferation
11/21/2002US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002US20020173457 Polypeptides
11/21/2002US20020173449 O-superfamily conotoxin peptides
11/21/2002US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002US20020172687 Anti-Viral Treatment With Pertussis Toxin B Oligomer
11/21/2002US20020172674 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
11/21/2002US20020172673 Method for down-regulating IgE
11/21/2002US20020172661 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata)
11/21/2002US20020172660 For therapy of cancer, viral infections
11/21/2002CA2689808A1 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
11/21/2002CA2460603A1 Unigene unidirectional antisense library
11/21/2002CA2451116A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
11/21/2002CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002CA2447286A1 Random gene unidirectional antisense library
11/21/2002CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002CA2446953A1 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002CA2446704A1 Method for preparing human immunoglobulin concentrates for therapeutic use
11/21/2002CA2446589A1 Methods for treating cancer
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002CA2446555A1 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002CA2446180A1 Cytokine polypeptides
11/21/2002CA2446108A1 Compositions for use in treating ige-associated disorders
11/21/2002CA2445366A1 Molecules for disease detection and treatment
11/21/2002CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002CA2443191A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/20/2002EP1257653A2 Phosphodiesterase type 7b
11/20/2002EP1257646A2 Transporters and ion channels
11/20/2002EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002EP1257583A2 METHODS FOR THE PREVENTION AND TREATMENT OF INFECTIONS USING ANTI-C3b(i) ANTIBODIES
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257565A1 Mucin-1 derived antigens and their use in immunotherapy
11/20/2002EP1257560A1 Bcl-2-like polynucleotides, polypeptides, and antibodies
11/20/2002EP1257558A1 Methods for synthesis of alpha-d-gal (1- 3) gal-containing oligosaccharides
11/20/2002EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002EP1257554A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments
11/20/2002EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002EP1257546A1 Kinase inhibitors
11/20/2002EP1257537A1 Therapeutic morpholino-substituted compounds
11/20/2002EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002EP1257527A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
11/20/2002EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002EP1257293A2 Immunomodulatory effective compositions, methods for the production thereof and their use
11/20/2002EP1257292A1 Use of il-18 inhibitors
11/20/2002EP1257290A2 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries
11/20/2002EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002EP1257270A1 A method for synthesizing leflunomide
11/20/2002EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002EP1047688B1 Thiophene nitrone compounds
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1172